These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34498714)

  • 1. Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Li Y; Qian X; Lin Y; Tao L; Zuo Z; Zhang H; Yang S; Cen X; Zhao Y
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway.
    Li Y; Tao L; Zuo Z; Zhou Y; Qian X; Lin Y; Jie H; Liu C; Li Z; Zhang H; Zhang H; Cen X; Yang S; Zhao Y
    Cancer Lett; 2019 Jul; 454():179-190. PubMed ID: 30978443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy.
    Liu H; Wei J; Sang N; Zhong X; Zhou X; Yang X; Zhang J; Zuo Z; Zhou Y; Yang S; Du J; Zhao Y
    Med Oncol; 2021 Sep; 38(10):124. PubMed ID: 34491469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer.
    Peng W; Zhang H; Tan S; Li Y; Zhou Y; Wang L; Liu C; Li Q; Cen X; Yang S; Zhao Y
    Ther Adv Med Oncol; 2020; 12():1758835920937428. PubMed ID: 32754230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.
    Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.
    Sang N; Zhong X; Gou K; Liu H; Xu J; Zhou Y; Zhou X; Liu Y; Chen Z; Zhou Y; Li Y; Tao L; Su N; Zhou L; Qiu J; Yang X; Zuo Z; Fu L; Zhang J; Li D; Li C; Sun Q; Lei J; Li R; Yang S; Cen X; Zhao Y
    MedComm (2020); 2023 Jun; 4(3):e269. PubMed ID: 37250145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted lipidomics reveals lipid metabolism disorders induced by oxathiapiprolin in Phytophthora sojae.
    Liu X; Li C; Chen Y; Xue Z; Miao J; Liu X
    Pest Manag Sci; 2023 Apr; 79(4):1593-1603. PubMed ID: 36562252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermolecular insights into allosteric inhibition of histone lysine-specific demethylase 1.
    Zhang X; Sun Y; Zhang Z; Wang H; Wang J; Zhao D
    Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129990. PubMed ID: 34390793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.
    Sonnemann J; Zimmermann M; Marx C; Ebert F; Becker S; Lauterjung ML; Beck JF
    Br J Haematol; 2018 Nov; 183(3):494-497. PubMed ID: 29205263
    [No Abstract]   [Full Text] [Related]  

  • 10. TSPAN8 promotes colorectal cancer cell growth and migration in LSD1-dependent manner.
    Zhang HS; Liu HY; Zhou Z; Sun HL; Liu MY
    Life Sci; 2020 Jan; 241():117114. PubMed ID: 31790687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in
    Miller SA; Policastro RA; Savant SS; Sriramkumar S; Ding N; Lu X; Mohammad HP; Cao S; Kalin JH; Cole PA; Zentner GE; O'Hagan HM
    Mol Cancer Res; 2020 Feb; 18(2):264-277. PubMed ID: 31704733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
    Hosseini A; Minucci S
    Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
    Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
    Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
    Sehrawat A; Gao L; Wang Y; Bankhead A; McWeeney SK; King CJ; Schwartzman J; Urrutia J; Bisson WH; Coleman DJ; Joshi SK; Kim DH; Sampson DA; Weinmann S; Kallakury BVS; Berry DL; Haque R; Van Den Eeden SK; Sharma S; Bearss J; Beer TM; Thomas GV; Heiser LM; Alumkal JJ
    Proc Natl Acad Sci U S A; 2018 May; 115(18):E4179-E4188. PubMed ID: 29581250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.
    Jin L; Hanigan CL; Wu Y; Wang W; Park BH; Woster PM; Casero RA
    Biochem J; 2013 Jan; 449(2):459-68. PubMed ID: 23072722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine-specific demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt/β-catenin pathway by down-regulating Dickkopf-1 (DKK1) [corrected].
    Huang Z; Li S; Song W; Li X; Li Q; Zhang Z; Han Y; Zhang X; Miao S; Du R; Wang L
    PLoS One; 2013; 8(7):e70077. PubMed ID: 23922913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-specific histone demethylase 1A (LSD1) in cervical cancer.
    Beilner D; Kuhn C; Kost BP; Jückstock J; Mayr D; Schmoeckel E; Dannecker C; Mahner S; Jeschke U; Heidegger HH
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2843-2850. PubMed ID: 32725356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
    Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
    Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
    Fiskus W; Sharma S; Shah B; Portier BP; Devaraj SG; Liu K; Iyer SP; Bearss D; Bhalla KN
    Leukemia; 2014 Nov; 28(11):2155-64. PubMed ID: 24699304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.